CATALYST PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of CN2 for the last quarter is 91.30 M EUR, and it's 8.86% lower compared to the previous quarter. The net income of Q1 24 is 21.57 M EUR.